This article requires a subscription to view the full text. If you have a subscription you may use the login form below to view the article. Access to this article can also be purchased.
This month’s Editor’s Choice is a multicenter, retrospective review of the use of home oxygen therapy in a group of subjects following hospitalization for COVID-19. Freedman and others found that one-quarter of subjects hospitalized for severe COVID-19 infection were discharged on home oxygen. Older age, higher body mass index, diabetes, greater severity of illness, and corticosteroid use were all associated with home oxygen requirement. At a 60-d follow-up, half of subjects were evaluated using pulse oximetry and half of those were able to have home oxygen discontinued. Crimi and colleagues provide commentary, noting the difficulty of conducting such a trial and congratulating the authors’ approach despite a modest sample size. They note that the use of home oxygen following admission for de novo respiratory failure was a new paradigm ushered in by the COVID-19 pandemic and call on clinical and research communities to be mindful of prescribing oxygen, carefully assess the need, recognize the impact on patients and caregivers, and detemine the burden of costs on the healthcare system.
Overbeek et al performed a multicenter cohort …
Pay Per Article - You may access this article (from the computer you are currently using) for 1 day for US$30.00
Regain Access - You can regain access to a recent Pay per Article purchase if your access period has not yet expired.
